Barmah Forest virus infection

Barmah Forest virus infection is a viral infection associated with the Barmah Forest virus and treated in the provided material as an Australian surveillance concept ^[1]. The evidence set here confirms that the condition has been the subject of journal articles and public-health bulletin material, including a factsheet and earlier clinical publications ^[5][2][3][4]. Source-backed detail on the virus family, formal case definition, or broader etiologic characterization is not yet available in the supplied snippets.

The source snippets do not provide a clinical syndrome description, symptom list, typical course, or complication profile for Barmah Forest virus infection, so those details should not be inferred ^{[1][5][2][3][4]}. One publication title indicates that glomerulonephritis has been described in association with Barmah Forest virus infection, but the snippet provides only bibliographic metadata and no clinical summary ^[5]. Beyond that title-level signal, source-backed detail on severity pattern, persistence, or recovery course is not yet available ^[5].

The available evidence places Barmah Forest virus infection in Australia and specifically discusses notifications across different geographical regions of that country ^[1]. In a scoping review, 30 of 406 screened studies met inclusion criteria, and the review found a positive association between higher temperatures and increased Barmah Forest virus notifications, with spatial variation noted across regions ^[1]. The same review states that more work is needed in inland regions and at smaller spatial scale, indicating a surveillance and knowledge gap rather than a fully settled epidemiologic picture ^[1]. No source-backed detail on reservoir, seasonality beyond temperature association, or outbreak magnitude is available in the provided material.

The provided snippets do not state the route of transmission, specific exposure mechanism, or vector/reservoir pathway for Barmah Forest virus infection, so these elements should be considered not yet available from source-backed evidence ^[1][2][3][4]. The only exposure-related information in the current set concerns an observed association between higher temperatures and increased notification risk in Australia ^[1]. Any more specific transmission statement would require additional source text.

The provided sources do not identify specific high-risk groups, age groups, occupational exposures, or other vulnerability categories for Barmah Forest virus infection ^{[1][5][2][3][4]}. The only population-level distinction stated in the review is geographic, with differing notification patterns across coastal and inland Australian regions ^[1]. Source-backed risk-group detail is therefore not yet available.

No direct prevention recommendations are contained in the supplied snippets, and the material does not specify personal protective measures, vector control, vaccination, or other exposure-control strategies ^[1][2][3][4]. The scoping review does note that spatial differences in temperature–notification relationships suggest the value of tailored prevention strategies, particularly in inland Australia, but it does not enumerate those strategies ^[1]. Source-backed prevention detail is therefore limited to the need for region-specific public-health planning ^[1].

For surveillance purposes, this entity should be read as an Australian notification-oriented viral infection concept rather than a fully described clinical syndrome in the present source set ^[1]. The most concrete monitoring signal available is the reported positive association between higher temperatures and increased Barmah Forest virus notifications, with geographic variation across Australian regions ^[1]. The literature base cited here also shows that barmah forest virus has appeared in journal and bulletin publications over time, but detailed case-definition or reporting thresholds are not present in the snippets ^[5][2][3][4].

1. 1 Varghese CM et al. The impact of temperature on Ross River virus and Barmah Forest virus infection in Australia: A scoping review. Aust N Z J Public Health. 2026 Feb. PMID: 41407624. doi: 10.1016/j.anzjph.2025.100291. PubMed: https://pubmed.ncbi.nlm.nih.gov/41407624/
2. 2 FactSheet: Barmah Forest virus infection. New South Wales Public Health Bulletin. 2002. doi: 10.1071/nb02069. DOI: https://doi.org/10.1071/nb02069
3. 3 Barmah Forest virus. The Lancet. 1991. doi: 10.1016/0140-6736(91)91575-f. DOI: https://doi.org/10.1016/0140-6736(91)91575-f
4. 4 Barmah Forest virus. Australian and New Zealand Journal of Medicine. 1990. doi: 10.1111/j.1445-5994.1990.tb00414.x. DOI: https://doi.org/10.1111/j.1445-5994.1990.tb00414.x
5. 5 Glomerulonephritis secondary to Barmah Forest virus infection. Medical Journal of Australia. 1997. doi: 10.5694/j.1326-5377.1997.tb138758.x. DOI: https://doi.org/10.5694/j.1326-5377.1997.tb138758.x
6. 6 Wikidata contributors. Barmah Forest virus infections in humans in New South Wales [Internet]. Wikidata. cited 20 May 2026. Available from: https://www.wikidata.org/wiki/Q45834441

ICD-10

ICD-11

Total cases

28K

Peak month

2013-03

Coverage

1 reporting countries · 2000-01-01 → 2026-06-01